The post Trump, Pfizer to announce agreement to lower Medicaid drug prices appeared on BitcoinEthereumNews.com. U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices to cheaper ones abroad. Trump will announce a drug pricing deal with Pfizer at 11 a.m. ET, a White House official told CNBC’s Eamon Javers. Pfizer CEO Albert Bourla will be in attendance, the official said. The agreement involves discounted prices in Medicaid and a three-year reprieve on planned pharmaceutical tariffs as long as the company is building manufacturing plants in the U.S., a source told CNBC’s Angelica Peebles. The deal comes as Pfizer and 16 other drugmakers face Trump’s Monday deadline to take steps to lower drug prices, as outlined in letters from the president. Pfizer did not immediately respond to a request for comment. The Washington Post first reported the news on Tuesday. Shares of Pfizer rose more than 3% on Tuesday after the report. Trump in May signed an executive order reviving a controversial plan, the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad. The deal comes as drugmakers brace for Trump’s planned tariffs on pharmaceuticals imported into the country. This is breaking news. Please refresh for updates. Source: https://www.cnbc.com/2025/09/30/trump-pfizer-drug-price-agreement.htmlThe post Trump, Pfizer to announce agreement to lower Medicaid drug prices appeared on BitcoinEthereumNews.com. U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices to cheaper ones abroad. Trump will announce a drug pricing deal with Pfizer at 11 a.m. ET, a White House official told CNBC’s Eamon Javers. Pfizer CEO Albert Bourla will be in attendance, the official said. The agreement involves discounted prices in Medicaid and a three-year reprieve on planned pharmaceutical tariffs as long as the company is building manufacturing plants in the U.S., a source told CNBC’s Angelica Peebles. The deal comes as Pfizer and 16 other drugmakers face Trump’s Monday deadline to take steps to lower drug prices, as outlined in letters from the president. Pfizer did not immediately respond to a request for comment. The Washington Post first reported the news on Tuesday. Shares of Pfizer rose more than 3% on Tuesday after the report. Trump in May signed an executive order reviving a controversial plan, the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad. The deal comes as drugmakers brace for Trump’s planned tariffs on pharmaceuticals imported into the country. This is breaking news. Please refresh for updates. Source: https://www.cnbc.com/2025/09/30/trump-pfizer-drug-price-agreement.html

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025.

Nathan Howard | Reuters

President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices to cheaper ones abroad.

Trump will announce a drug pricing deal with Pfizer at 11 a.m. ET, a White House official told CNBC’s Eamon Javers. Pfizer CEO Albert Bourla will be in attendance, the official said.

The agreement involves discounted prices in Medicaid and a three-year reprieve on planned pharmaceutical tariffs as long as the company is building manufacturing plants in the U.S., a source told CNBC’s Angelica Peebles.

The deal comes as Pfizer and 16 other drugmakers face Trump’s Monday deadline to take steps to lower drug prices, as outlined in letters from the president.

Pfizer did not immediately respond to a request for comment. The Washington Post first reported the news on Tuesday.

Shares of Pfizer rose more than 3% on Tuesday after the report.

Trump in May signed an executive order reviving a controversial plan, the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad.

The deal comes as drugmakers brace for Trump’s planned tariffs on pharmaceuticals imported into the country.

This is breaking news. Please refresh for updates.

Source: https://www.cnbc.com/2025/09/30/trump-pfizer-drug-price-agreement.html

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$4.963
$4.963$4.963
-4.28%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin Supports Native Rollup Integration on Ethereum

Vitalik Buterin Supports Native Rollup Integration on Ethereum

The post Vitalik Buterin Supports Native Rollup Integration on Ethereum appeared on BitcoinEthereumNews.com. Key Points: Vitalik Buterin supports ZK Rollups for
Share
BitcoinEthereumNews2026/01/19 15:43
Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports

Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports

The post Fan Token Firm Chiliz Acquires 2-Time ‘Dota 2’ Champions, OG Esports appeared on BitcoinEthereumNews.com. In brief The Chiliz Group has acquired a controlling stake in OG Esports, a prominent competitive gaming organization. OG Esports unveiled its own fan token on Chiliz’s Socios.com platform back in 2020. It recently hit an all-time high price. Chiliz has teased various future team-related benefits for OG token holders, along with a new Web3-related project. The Chiliz Group, which operates the Socios.com crypto fan token platform, announced Tuesday that it has acquired a 51% controlling stake in OG Esports, the competitive gaming organization founded in 2015 by Dota 2 legends Johan “nOtail” Sundstein and Sébastien “Ceb” Debs. OG made history as the first team to win consecutive titles at The International—the annual, high-profile Dota 2 world championship tournament—in 2018 and 2019, and has since expanded into multiple games including Counter-Strike, Honor of Kings, and Marvel Rivals. The team was also the first esports organization to join the Socios platform with the 2020 debut of its own fan token, which Chiliz said recently became the first esports team token to exceed a $100 million market capitalization. OG was recently priced at $16.88, up nearly 9% on the day following the announcement. The token’s price peaked at a new all-time high of $24.78 last week ahead of The International 2025, where OG did not compete this year. Following the acquisition, Xavier Oswald will assume the CEO role, while the co-founders will turn their attention to “a new strategic project consolidating the team’s competitive foundation [and] driving innovation at the intersection of esports and Web3,” per a press release. No further details were provided regarding that project. “Bringing OG into the Chiliz Group is a major step toward further strengthening fan experiences, one where the community doesn’t just watch from the sidelines but gets to shape the journey,” Chiliz CEO Alex Dreyfus…
Share
BitcoinEthereumNews2025/09/18 09:40
NEAR Price Prediction: Testing Critical $1.88 Resistance with $2.10-$2.35 Targets by February 2026

NEAR Price Prediction: Testing Critical $1.88 Resistance with $2.10-$2.35 Targets by February 2026

The post NEAR Price Prediction: Testing Critical $1.88 Resistance with $2.10-$2.35 Targets by February 2026 appeared on BitcoinEthereumNews.com. Rebeca Moen
Share
BitcoinEthereumNews2026/01/19 15:34